Meeting our partners’ varied and evolving needs, Celentyx’s services utilise the proprietary Immuno-Profiling™ platform to provide rapid analysis of drug action on physiological and pathological human immune tissues and cells. This series of intelligent screening methodologies incorporates robust and state-of-the-art techniques, and draws on the world-leading expertise of Celentyx personnel.
Celentyx offers access to our powerful Immuno-Profiling™ platform and extensive in-house expertise through our tailored fee-based research services.
Tailored to give valuable information on:
- mechanism of action (molecular and cellular), efficacy & safety on human immune cells
- maturing and/or mature immune cells
- normal resting, activated and/or pathological immune cells relevant to immunological diseases (e.g. inflammation, haematological cancers, allergy & autoimmune diseases)
- isolated cell types and custom admixes
- relevant data derived from small molecules and monoclonal antibodies (allowing use of final unmodified biologicals) allows early pipeline rationalisation prior to first administration to man
To discuss our Immuno-Profiling™ services please contact our Commercial Manager Dr Catherine Brady